China
· Delayed Price · Currency is CNY Beijing Hotgen Biotech Statistics
Total Valuation
SHA:688068 has a market cap or net worth of CNY 9.27 billion. The enterprise value is 8.58 billion.
| Market Cap | 9.27B |
| Enterprise Value | 8.58B |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688068 has 89.58 million shares outstanding. The number of shares has increased by 8.41% in one year.
| Current Share Class | 89.58M |
| Shares Outstanding | 89.58M |
| Shares Change (YoY) | +8.41% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 31.82% |
| Owned by Institutions (%) | 10.19% |
| Float | 56.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 172.50 |
| PS Ratio | 19.00 |
| PB Ratio | 3.11 |
| P/TBV Ratio | 3.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -41.20 |
| EV / Sales | 17.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.37 |
| Quick Ratio | 3.14 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -476.97 |
Financial Efficiency
Return on equity (ROE) is -6.62% and return on invested capital (ROIC) is -3.96%.
| Return on Equity (ROE) | -6.62% |
| Return on Assets (ROA) | -3.70% |
| Return on Invested Capital (ROIC) | -3.96% |
| Return on Capital Employed (ROCE) | -6.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 1,036 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +225.52% in the last 52 weeks. The beta is 1.59, so SHA:688068's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +225.52% |
| 50-Day Moving Average | 100.30 |
| 200-Day Moving Average | 56.21 |
| Relative Strength Index (RSI) | 41.78 |
| Average Volume (20 Days) | 2,672,579 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688068 had revenue of CNY 488.01 million and -208.29 million in losses. Loss per share was -2.21.
| Revenue | 488.01M |
| Gross Profit | 486.41M |
| Operating Income | -200.18M |
| Pretax Income | -205.22M |
| Net Income | -208.29M |
| EBITDA | n/a |
| EBIT | -200.18M |
| Loss Per Share | -2.21 |
Balance Sheet
The company has 737.70 million in cash and 50.12 million in debt, giving a net cash position of 687.58 million or 7.68 per share.
| Cash & Cash Equivalents | 737.70M |
| Total Debt | 50.12M |
| Net Cash | 687.58M |
| Net Cash Per Share | 7.68 |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 32.32 |
| Working Capital | 1.20B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 99.67%, with operating and profit margins of -41.02% and -42.68%.
| Gross Margin | 99.67% |
| Operating Margin | -41.02% |
| Pretax Margin | -42.05% |
| Profit Margin | -42.68% |
| EBITDA Margin | n/a |
| EBIT Margin | -41.02% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.18%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.41% |
| Shareholder Yield | -8.22% |
| Earnings Yield | -2.25% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 16, 2022. It was a forward split with a ratio of 1.48.
| Last Split Date | Jun 16, 2022 |
| Split Type | Forward |
| Split Ratio | 1.48 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |